Evaluation of the Benefits for Overall Health Following Cochlear Implant Treatment in the Elderly Population

Overview

The purpose of this study is to show that cochlear implant treatment improves the overall health related quality of life and general well-being in elderly individuals.

Full Title of Study: “Cochlear Implant and Healthy Aging: A Multinational, Multicentre Observational Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 21, 2022

Detailed Description

The study is designed as an observational prospective repeated measures study with each subject acting as his/her own control. Subjects are evaluated subjectively at pre- and post-operative intervals that coincide with their routine visits to the clinic. Outcomes from routine practice and application of cochlear implant intervention are recorded through observational measures using clinical standards scales used widely in geriatrics and audiology. The study is aimed at collection of data for patients who have already made the decision together with their implant centre clinician for an implant device from the company Cochlear. Patients are approached for study participation prior to surgery by the caring clinician on a consecutive and voluntary basis and on condition of signing the patient informed consent.

Interventions

  • Device: Commercial Nucleus Cochlear Implant Systems
    • Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality

Arms, Groups and Cohorts

  • Commercial Nucleus Cochlear Implant Systems

Clinical Trial Outcome Measures

Primary Measures

  • Change in Health Related Quality of Life Following Cochlear Implant Treatment
    • Time Frame: pre-implant surgery, 12 months post-surgery
    • Assessed via the Health Utilities Index Mark III (HUI 3) questionnaire. HUI-3 classification system consists of 8 attributes including vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain. HUI-3 values range from -0.36 to 1.00. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The change in scores is presented. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life.
  • Change in Health Related Quality of Life Following Cochlear Implant Treatment
    • Time Frame: pre-implant surgery, 18 months post-surgery
    • Assessed via the Health Utilities Index Mark III (HUI 3) questionnaire. HUI-3 classification system consists of 8 attributes including vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain. HUI-3 values range from -0.36 to 1.00. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The change in scores will be presented. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life.

Participating in This Clinical Trial

Inclusion Criteria

  • Unilateral CI candidates with bilateral post-lingual deafness with intention to treat – ≥ 60 years at first unilateral cochlear implant – Implant ear: meets all local criteria for cochlear implant treatment – Contralateral ear: average pure tone thresholds indicate a moderately-severe to profound hearing loss (4 freq. average: 0.5, 1, 2 and 3 or 4 kHz > 56 dBHL). – Willingness to participate in and to comply with all study procedures – Fluency in languages used to assess clinical performance – Appropriate expectations from routine cochlear implant treatment – Able to decide on study participation personally and independently sign their consent Exclusion Criteria:

  • Significantly/severely dependent or fragile – Unable to provide consent personally – Unable to complete questionnaires for self-assessment independently – Unilateral hearing loss – Sequential and simultaneous bilateral cochlear implant recipients – Ossification or other cochlear anomalies preventing full electrode insertion – Retro cochlear or central origins of hearing impairment. – Significant comorbidities preventing study participation (e.g. blindness, immobility or in a wheel chair, severe aphasia) – Medical contraindications to surgery – Clinic Standard fail criteria for cochlear implant candidacy in regards to chronic depression, dementia, and cognitive disorders. – Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device.

Gender Eligibility: All

Minimum Age: 60 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Cochlear
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Bart Volckaerts, PhD, Study Director, Cochlear

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.